David Warnock
Overview
Explore the profile of David Warnock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeys L, Morris G, Kurisunkal V, Botello E, Boyle R, Ebeid W, et al.
Bone Joint J
. 2025 Jan;
107-B(2):246-252.
PMID: 39889743
Aims: The Birmingham Orthopaedic Oncology Meeting (BOOM), held in January 2024, convened 309 delegates from 53 countries to discuss and refine 21 consensus statements on the optimal management of chondrosarcoma....
2.
3.
Jeys L, Thorkildsen J, Kurisunkal V, Puri A, Ruggieri P, Houdek M, et al.
Bone Joint J
. 2024 May;
106-B(5):425-429.
PMID: 38689572
Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of...
4.
Fall B, Scott C, Mauer M, Shankland S, Pippin J, Jefferson J, et al.
PLoS One
. 2016 Dec;
11(12):e0168346.
PMID: 27992580
Chronic kidney disease is a major complication of Fabry disease. Podocytes accumulate globotriaosylceramide inclusions more than other kidney cell types in Fabry patients. Podocyte injury occurs early in age, and...
5.
Tanner R, Calhoun D, Bell E, Bowling C, Gutierrez O, Irvin M, et al.
Clin J Am Soc Nephrol
. 2013 Jul;
8(9):1583-90.
PMID: 23868902
Background And Objectives: Apparent treatment-resistant hypertension is defined as systolic/diastolic BP ≥ 140/90 mmHg with concurrent use of three or more antihypertensive medication classes or use of four or more...
6.
Tanner R, Gutierrez O, Judd S, McClellan W, Bowling C, Bradbury B, et al.
Am J Kidney Dis
. 2012 Dec;
61(3):395-403.
PMID: 23228944
Background: It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States....
7.
Warnock D, McGee-Lennon M, Brewster S
Health Informatics J
. 2012 Sep;
18(3):181-90.
PMID: 23011813
The primary users of assisted living technology are older people who are likely to have one or more sensory impairments. Multimodal technology allows users to interact via non-impaired senses and...
8.
Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai N, Bradbury B, et al.
Am J Kidney Dis
. 2011 Aug;
58(5):756-63.
PMID: 21816528
Background: Albuminuria and estimated glomerular filtration rate (eGFR) are each associated with increased risk of cognitive impairment, but their joint association is unknown. Study Design: Prospective cohort study. Setting &...
9.
Peralta C, Shlipak M, Judd S, Cushman M, McClellan W, Zakai N, et al.
JAMA
. 2011 Apr;
305(15):1545-52.
PMID: 21482744
Context: A triple-marker approach for chronic kidney disease (CKD) evaluation has not been well studied. Objective: To evaluate whether combining creatinine, cystatin C, and urine albumin-to-creatinine ratio (ACR) would improve...
10.
Hage F, de Mattos A, Khamash H, Mehta S, Warnock D, Iskandrian A
Clin Cardiol
. 2010 Jun;
33(6):361-6.
PMID: 20556806
Background: Coronary artery disease (CAD) is the predominant cause of sudden cardiac death in the general population, and sudden cardiac death is the leading cause of mortality in end-stage renal...